share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I

福泰製藥 | 4:持股變動聲明-董事 SACHS BRUCE I
美股sec公告 ·  05/24 16:19
Moomoo AI 已提取核心訊息
On May 22, 2024, Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 7,073 shares of common stock at a price of $448.00 per share. The transaction resulted in a total market value of $3,168,704. Following the sale, Sachs directly holds 40,000 shares of Vertex Pharmaceuticals. The sale was executed in the open market and is part of Sachs' direct holdings in the company. This financial activity reflects Sachs' latest dealings with Vertex Pharmaceuticals' stock, providing investors with updated insider transaction information.
On May 22, 2024, Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 7,073 shares of common stock at a price of $448.00 per share. The transaction resulted in a total market value of $3,168,704. Following the sale, Sachs directly holds 40,000 shares of Vertex Pharmaceuticals. The sale was executed in the open market and is part of Sachs' direct holdings in the company. This financial activity reflects Sachs' latest dealings with Vertex Pharmaceuticals' stock, providing investors with updated insider transaction information.
2024年5月22日,與Vertex Pharmicals Inc.(VRTX)關聯的布魯斯一世薩克斯以每股448.00美元的價格完成了7,073股普通股的出售。該交易的總市值爲3,168,704美元。出售後,薩克斯直接持有Vertex Pharmicals的40,000股股份。此次出售是在公開市場上進行的,是薩克斯在公司的直接持股的一部分。該財務活動反映了薩克斯與Vertex Pharmaceuticals股票的最新交易,爲投資者提供了最新的內幕交易信息。
2024年5月22日,與Vertex Pharmicals Inc.(VRTX)關聯的布魯斯一世薩克斯以每股448.00美元的價格完成了7,073股普通股的出售。該交易的總市值爲3,168,704美元。出售後,薩克斯直接持有Vertex Pharmicals的40,000股股份。此次出售是在公開市場上進行的,是薩克斯在公司的直接持股的一部分。該財務活動反映了薩克斯與Vertex Pharmaceuticals股票的最新交易,爲投資者提供了最新的內幕交易信息。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息